18 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
28650658	54	Potent, Selective, and Cell Active Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor Developed by Structure-Based Virtual Screening and Hit Optimization.	Shandong University
26428871	11	Discovery and structure-activity analysis of 4-((5-nitropyrimidin-4-yl)amino)benzimidamide derivatives as novel protein arginine methyltransferase 1 (PRMT1) inhibitors.	Sichuan University
25893041	12	Discovery of a Dual PRMT5-PRMT7 Inhibitor.	University Of Toronto
25559100	25	Exploration of cyanine compounds as selective inhibitors of protein arginine methyltransferases: synthesis and biological evaluation.	The University Of Georgia
25032507	43	Discovery of a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8.	University Of North Carolina At Chapel Hill
24564570	12	Diamidine compounds for selective inhibition of protein arginine methyltransferase 1.	The University Of Georgia
23433670	15	Bromo-deaza-SAH: a potent and selective DOT1L inhibitor.	Entremed
24900432	51	Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2.	TBA
22749641	15	Synthesis and evaluation of carbocyanine dyes as PRMT inhibitors and imaging agents.	Georgia State University
29019697	24	Development of Potent Type I Protein Arginine Methyltransferase (PRMT) Inhibitors of Leukemia Cell Proliferation.	Zhejiang Sci-Tech University
28135235	71	An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED.	Novartis Institutes For Biomedical Research
17705362	43	Synthesis and characterization of nonsteroidal glucocorticoid receptor modulators for multiple myeloma.	Ligand Pharmaceuticals